The Trinity Challenge on Community Access to Effective Antibiotics is now open!

Find out more and apply here

Our Challenge on Community Access to Effective Antibiotics

The Trinity Challenge is a call to action for the best and brightest minds to contribute ideas and innovations, with a chance to win both funding and mentoring from world-renowned organisations.

What is the Trinity Challenge on Community Access to Effective Antibiotics?

The Trinity Challenge on Community Access to Effective Antibiotics is now live!

This latest Challenge is our call for low-cost tech and data-driven solutions to improve access to effective antibiotics in community settings in low- and middle-income countries.

We are calling for innovators to answer the question: How can data and technology improve stock control and/or reduce the use of substandard and falsified oral antibiotics for community use in low-and middle-income countries?

 

 

Antibiotic resistance (often referred to as antimicrobial resistance or AMR) is a One Health crisis, and an increasing threat to our health, food, and environmental security. 

It is estimated that antibiotic resistance will cause 39 million deaths in the next 25 years. Without action, the majority of deaths will occur within low- and middle-income countries (LMICs).

The Challenge is particularly interested in the following two drivers of antibiotic resistance:

Stock control 

There is a lack of stock control at the sub-national/local level in community settings.

Interruptions may occur anywhere along the continuum from manufacture to dispensing of antibiotics. This can lead to a situation where there is no available supply of a specific antibiotic within the community (a stockout), which may in turn increase the likelihood of substandard antibiotics entering the market.

Substandard and falsified antibiotics 

Substandard and falsified antibiotics are estimated to make up 10% of antimicrobials used by humans in LMICs and 6.5% of veterinary medicines.

Substandard antibiotics are authorised medicines that fail to meet either their quality standards, their specifications, or both. Falsified antibiotics deliberately or fraudulently misrepresent their identity, composition, or source.

Eligibility

The Challenge in inviting solutions that can be submitted over two years, and which include the following elements:

LMICs

Focus on low- and middle-income communities, led by LMIC orgs or with bona fide in-country partnerships.

Community

Use or generate community-level data – i.e. outside of formal healthcare and industry settings.

Innovation

Use new or adapted data or technology, application of data or digital tools/analytics.

One Health

Focus on human health, animal health, environmental health, or any combination therein.

Impact

Provide a public benefit that would be globally accessible under fair, reasonable and non-discriminatory terms

Scalability

Demonstrate the potential to scale to positively affect the lives of LMIC populations

Our Challenge Funding Members

Some of the world’s preeminent institutions are Members of The Trinity Challenge, including leaders across academe, social and private sectors. To see all our Members, including who have supported previous Challenges, visit our Members page.